Specialty drugs continue to dominate pharmacy spend and complicate benefit decisions. Grounded in employer perspective market research and real-world data, this session shows how to translate pipeline intelligence into action. Learn how employers can anticipate emerging therapies, forecast budget impact, and apply clinical strategies that balance affordability with outcomes.